Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.1201
+0.0026 (2.21%)
Aug 1, 2025, 3:56 PM EDT
Accolade Market Cap
Vivos has a market cap or net worth of $56.69 million as of August 1, 2025. Its market cap has decreased by -28.09% in one year.
Market Cap
56.69M
Enterprise Value
62.77M
Revenue
50.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 56.69M, an increase of 369.16%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 56.69M | 12.33% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | 30.61M | 348.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |